Zantac Injury Attorneys | Consumer Help Group

Zantac Law Suits

Zantac, once a popular heartburn medication, has been linked to cancer due to the presence of a dangerous carcinogen.

If you or a loved one have been diagnosed with cancer after using Zantac, you may be eligible for compensation. Our experienced legal team is here to help you navigate the Zantac lawsuit process and fight for your rights.

ZANTAC LAW SUITS

A Zantac lawsuit is a legal claim for financial compensation by plaintiffs who took the heartburn medication and were later diagnosed with cancer. Zantac (and the generic version ranitidine) contained the carcinogen NDMA. Studies have linked this hepatotoxin to cancer in both animals and humans.

In the current 2022 litigation, plaintiffs allege that Zantac makers placed a dangerous product on the market and failed to warn consumers of the serious risks and side effects. On April 1, 2020, the U.S. Food and Drug Administration (FDA) requested that all companies withdraw their ranitidine products.

The FDA had found “unacceptable amounts” of NDMA in the ingredient ranitidine. Since then, more than a dozen pharmaceutical companies have recalled the drug.

The ranitidine lawsuits are not part of a class action. Instead, these are individual lawsuits of the victim against the drugmaker. Many of the claims will join into multidistrict litigation (MDL). This will expedite the litigation and settlement process.

Get Free Case Review

Name

Last Name

phone

Address

Did you serve anytime between 2003-2015?

Did you wear Combat Arms Earplugs?

Did you suffer hearing loss or tinnitus?

Do you already have an attorney representing this claim?

I Agree to Terms of Service and Privacy Policy provided by Consumer Help Group. By providing my phone number, I agree to receive text messages from Consumer Help Group. I understand I can SMS opt-out at any time by responding "Stop".

We build trust, understand needs and provide solutions

Who qualifies for Zantac lawsuits?

In terms of case criteria, our firm is accepting cases where the person took Zantac– or a combination of Zantac and ranitidine – for at least once a week for a minimum of one year and afterwards was diagnosed with any of the following five types of cancer: